SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The community is debating a recent campaign proposal that would offer a $5,000 dividend to U.S. citizens if the Republican party maintains control of Congress. Traders are sharply divided, with critics labeling the plan as a desperate bribe or an inflationary fiscal disaster, while supporters are highlighting the potential economic benefits.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The conversation is dominated by concerns over rising oil prices and surging Treasury yields, with many traders speculating on upcoming inflation data. Sentiment is divided between bearish outlooks citing these macroeconomic pressures and bullish retail participants who are betting on potential market interventions or political stimulus promises.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing heightened volatility and bearish sentiment as investors process a combination of rising oil prices, elevated long-term Treasury yields, and uncertainty regarding upcoming inflation data. Market participants are expressing significant division, with many reacting to the broader macro pressures and concerns about the Federal Reserve's next policy moves.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as traders react to escalating geopolitical tensions in the Middle East, particularly around the Strait of Hormuz, which continues to drive oil prices higher despite speculative uncertainty. The community remains deeply divided, with many debating whether the rally is sustainable or driven by market manipulation, while others speculate on the potential for future diplomatic interventions or price reversals.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike shares remain under intense downward pressure as investors react to the company's exclusion from the S&P 100 and ongoing concerns regarding weak earnings, competition, and China sales. While the community is deeply divided between those viewing the stock as a long-term value opportunity and those aggressively shorting the stock amid a perceived failed turnaround, sentiment remains predominantly bearish.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following an aggressive AI growth outlook from the company's CFO, which projects a massive increase in the total addressable market by 2030, alongside positive analyst initiations and price target hikes. Community sentiment is largely bullish as the stock demonstrates relative strength compared to the broader market, though some traders remain skeptical of the valuation and express concern over potential volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are trending following the company's hardware product launch, which featured the debut of the iPhone Duo, a new foldable smartphone starting at $1,999. While community reaction is divided between optimism over the device's innovation and skepticism regarding its high price point, retail sentiment has shifted toward bullishness as traders assess potential impacts on revenue and market share.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are trending following the launch of Muse, a personal AI agent designed to perform autonomous tasks such as scheduling, shopping, and email management. While community reaction is divided between optimism over the new monetization potential and skepticism regarding the effectiveness of Meta's AI-driven strategy, the stock has also received positive analyst upgrades.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares saw upward momentum following a strong fiscal first-quarter earnings beat and record-breaking backlog growth. While traders remain divided on the stock's valuation and the company's unchanged full-year guidance, sentiment is supported by ongoing demand for autonomous defense systems and recent high-profile contract wins.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending following reports that the company is developing advanced EMIB-style packaging technology to compete more directly with Intel as AI chip demand increases. Investors are also digesting monthly revenue growth figures and news of an expanded joint venture with Sony.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRMD Quick look over at the gainers for today and I saw this grouping.  How many Buyouts or deals did we have in this group?  Good lord.  Will $CRMD be added to that distinguished list?  I think so.    
 
For fun, the 2 picks above the screen grab was $AKRO, one below was $NUVL.  $TERN?  $VRNA?  Some real life changes in here. 
 
Follow/Subscribe for more suggestions and perspective.  Would love to hear yours too. That&#39;s how we find these gems and learn. 
 
Let&#39;s make some (more) money.  Cheers!

KpMocZ

StockTwits Web

CorMedix Inc

Akero Therapeutics Inc

Nuvalent Inc - Ordinary Shares - Class A

Terns Pharmaceuticals Inc

Verona Pharma Plc American Depositary

 Quick look over at the gainers for today and I saw this grouping.  How many Buyouts or deals did we have in this group?  Good lord.  Will 

 be added to that distinguished list?  I think so.    
 
For fun, the 2 picks above the screen grab was 

?  Some real life changes in here. 
 
Follow/Subscribe for more suggestions and perspective.  Would love to hear yours too. That's how we find these gems and learn. 
 
Let's make some (more) money.  Cheers!

The Legendary Mayor

@BioRich have you been in crmd a while? I’ve been here 8 years. Long road…. 
What makes you believe it will be bought out?

StockTwits for iOS

 have you been in crmd a while? I’ve been here 8 years. Long road…. 
What makes you believe it will be bought out?

Teddy BallGame

@tballgame I&#39;ve been in it for awhile as well.  Been a portfolio staple, albeit some ebbs and flows along the way.  The real world feedback on DefenCath is undeniable, and having already achieving valuable revenue streams after FDA approval, I think it&#39;s just the type of niche product Big Pharma would love to have in their stable.  
 
While the term &quot;de-risked&quot; is grossly overused on these boards, I believe $CRMD fits the spirit of &quot;de-risked&quot; at this point.  Whether a BO happens or not, I still believe it&#39;s a very strong Buy.   
 
What are your thoughts?

 I've been in it for awhile as well.  Been a portfolio staple, albeit some ebbs and flows along the way.  The real world feedback on DefenCath is undeniable, and having already achieving valuable revenue streams after FDA approval, I think it's just the type of niche product Big Pharma would love to have in their stable.  
 
While the term "de-risked" is grossly overused on these boards, I believe 

 fits the spirit of "de-risked" at this point.  Whether a BO happens or not, I still believe it's a very strong Buy.   
 
What are your thoughts?

@BioRich I hear that- i’m not sure on the buyout… while I agree with the sentiment a large Pharma company would like this in their portfolio, I think cormedix is very expensive at this point, sits on uncertainty with reimbursement (= not confident 5-10year projections), and they seem more interested in developing themselves as a pharmaceutical company with multiple lines of products. 

I do agree it is “Derisked” from many perspectives, however market sentiment because of TDAPA drop off this summer and the lack of an immediate replacement has hammered the share price following decreased guidance, and a lot of longs are concerned the market will react again when we drop off the cliff.

 I hear that- i’m not sure on the buyout… while I agree with the sentiment a large Pharma company would like this in their portfolio, I think cormedix is very expensive at this point, sits on uncertainty with reimbursement (= not confident 5-10year projections), and they seem more interested in developing themselves as a pharmaceutical company with multiple lines of products. 

I do agree it is “Derisked” from many perspectives, however market sentiment because of TDAPA drop off this summer and the lack of an immediate replacement has hammered the share price following decreased guidance, and a lot of longs are concerned the market will react again when we drop off the cliff.

@tballgame This all makes a ton of sense, and is a very real concern.  Don&#39;t know this management team well, but from what I do remember, I thought they were pretty legit.  Is that one of their strengths or more of a cowboy GIA for ego group?

 This all makes a ton of sense, and is a very real concern.  Don't know this management team well, but from what I do remember, I thought they were pretty legit.  Is that one of their strengths or more of a cowboy GIA for ego group?

@BioRich I’m not sure on how I’d grade leadership. Very hard to grade and judge from afar. It seems like the overall team is growing for scaling the product lines, and a recent tech leader add was intriguing. 

The past CEO was awful, but honestly I don’t know how much better the new one is. Most times he speaks the share price drops, most longs and the market did not like the TLPH purchase or other statements he makes about inorganic growth and the January guidance lowball really set share price on a spiral down. 

I think the greatest hurdle is the government passing KCAPA and MA reimbursement agreement. Those two things alone could dramatically change the trajectory. 

Another big driver would be expanded use of defencath. TPN use would be big and so would oncology.  I believe TPN studies are ongoing and expected 2027.

 I’m not sure on how I’d grade leadership. Very hard to grade and judge from afar. It seems like the overall team is growing for scaling the product lines, and a recent tech leader add was intriguing. 

The past CEO was awful, but honestly I don’t know how much better the new one is. Most times he speaks the share price drops, most longs and the market did not like the TLPH purchase or other statements he makes about inorganic growth and the January guidance lowball really set share price on a spiral down. 

I think the greatest hurdle is the government passing KCAPA and MA reimbursement agreement. Those two things alone could dramatically change the trajectory. 

Another big driver would be expanded use of defencath. TPN use would be big and so would oncology.  I believe TPN studies are ongoing and expected 2027.